The situation in Greece and Europe "is slipping out of the control of the politicians." Mohamed El-Erian says.» Read More
Markets tumbled Friday, but one portfolio manager told CNBC he expects the "garden variety pullback" to be short-lived.
Here are the stocks to watch heading out of this weekend's American College of Cardiology conference in San Diego.
There's a new term used around the oil patch these days. You better learn it if you're going to catch the bottom in oil.
Weak oil revenues and the strong dollar is weighing on earnings expectations for the markets.
The Obama administration is not working with Congress on an Iran nuclear deal because it is afraid to explain itself, Sen. Bob Corker tells CNBC.
Valeant chief Michael Pearson won't pay too much for Salix, which earlier this week received a competing offer from Endo, Bill Ackman tells CNBC.
The activist investor tells CNBC he has not been contacted by the FBI or the Justice Department regarding his campaign against Herbalife.
CNBC's Jim Cramer tells of his surprise when Apple's Tim Cook called into his special "Mad Money" tenth anniversary show Thursday night. Also Cramer shares his thoughts on Bill Ackman's interview on Herbalife, and his concern about Petrobras debt.
CNBC's Meg Tirrell provides a preview of this weekend's American College of Cardiology meeting and the new drugs that will likely dominate the headlines.
Joe Hinrichs, Ford president of the Americas, discuss the official production of Ford's hugely popular F-150.
CNBC's Steve Liesman, and John Ryding, RDQ Economics, dissect the latest PPI data and what it indicates about the economy. It is not a deflationary environment apart from lower oil prices, says Ryding.
CNBC's Rick Santelli breaks down the latest data on producer prices and what it indicates about the U.S. economy and its impact on Treasurys.
Sen. Bob Corker, (R-Tenn.), explains why he thinks any effort by the Obama administration to bypass Congress and to straight to the UN to implement a nuclear agreement would be "a direct affront to the American people."
Remember to track the investments of the top money managers on Wall Street at "Squawk Box Platinum Portfolio" on CNBC Pro.
CNBC's Scott Wapner and Bill Ackman, Pershing Square Capital Management, weighs in on Valeant's bid for Salix. We think Valeant stock is very cheap, says Ackman.
Bill Ackman, Pershing Square Capital Management, says he is not making false statements about Herbalife and stands behind his words about the company.
CNBC's Scott Wapner and Bill Ackman, Pershing Square Capital Management, discuss the Fed's investigation of Herbalife. I don't know more than what I read in the papers, says Ackman. And Ackman continues to assert Herbalife is a pyramid scheme.
Mary Dillon, Ulta Beauty CEO, weighs in on the company's growth strategy and the pulse of the consumer.
Edward Morse, Citi commodities research, discusses what's driving oil price lower as the commodity wanders further into bear territory.
Apple's Tim Cook called into "Mad Money's" 10th anniversary show to talk to a surprised Jim Cramer. Never one to miss an opportunity, Cramer asked the CEO about where he sees the next frontier in technology.
Get the best of CNBC in your inbox